Agenda
Times are displayed in the event's local time (GMT -04:00)
AstraZeneca has provided a sponsorship grant towards this independent program
10:29
Conference Opening & Welcome
10:30 - 10:50
Tissue acquisition and staging, role of pulmonologists
10:50 - 11:08
Stereotactic radiation for non-surgical patients
11:08 - 11:20
Surgical approaches and the evolving role of surgeons in the management of NSCLC
11:20 - 11:36
Role of IO in the adjuvant setting
11:36 - 11:49
Moving targeted therapy to the adjuvant setting in NSCLC
11:49 - 12:07
Neoadjuvant treatment options for Lung Cancer
12:07 - 12:10
Short Break
12:10 - 12:50
LIVE Panel Discussion/Q&A 1
12:50 - 12:51
Message from Bristol Myers Squibb
12:51 - 13:11
Concurrent chemo-RT followed by IO, updates and future
13:11 - 13:30
EGFR directed therapy, where do the next advances come from?
13:30 - 13:55
ALK, ROS1, and other rare molecular subtypes of non-small cell lung cancer: what is new?
13:55 - 13:57
Message from Bristol Myers Squibb
13:57 - 14:10
Short Break
14:10 - 14:50
A Treatment Option for Patients with First-Line Metastatic Non-Small Cell Lung Cancer + Q&A - LIVE Satellite Symposium Sponsored by Bristol Myers Squibb (This program is intended for US Healthcare Professionals only)
14:50 - 15:10
Chemotherapy plus IO for metastatic disease
15:10 - 15:30
IO/IO approaches for treatment of NSCLC
15:30 - 15:48
The Evolution of Palliative Care in Cancer Care
15:50